Design, Dimerization, and Recombinant Production of MCh-AMP1–Derived Peptide in Escherichia coli and Evaluation of Its Antifungal Activity and Cytotoxicity

Fungal species resistant to current antifungal agents are considered as a serious threat to human health, the dilemma that has dragged attentions toward other sources of antifungals such as antimicrobial peptides (AMPs). In order to improve biological activity of a recently described antifungal pept...

Full description

Bibliographic Details
Main Authors: Sima Sadat Seyedjavadi, Soghra Khani, Jafar Amani, Raheleh Halabian, Mehdi Goudarzi, Hamideh Mahmoodzadeh Hosseini, Ali Eslamifar, Masoomeh Shams-Ghahfarokhi, Abbas Ali Imani Fooladi, Mehdi Razzaghi-Abyaneh
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Fungal Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/ffunb.2021.638595/full
_version_ 1819076035773202432
author Sima Sadat Seyedjavadi
Soghra Khani
Jafar Amani
Raheleh Halabian
Mehdi Goudarzi
Hamideh Mahmoodzadeh Hosseini
Ali Eslamifar
Masoomeh Shams-Ghahfarokhi
Abbas Ali Imani Fooladi
Mehdi Razzaghi-Abyaneh
author_facet Sima Sadat Seyedjavadi
Soghra Khani
Jafar Amani
Raheleh Halabian
Mehdi Goudarzi
Hamideh Mahmoodzadeh Hosseini
Ali Eslamifar
Masoomeh Shams-Ghahfarokhi
Abbas Ali Imani Fooladi
Mehdi Razzaghi-Abyaneh
author_sort Sima Sadat Seyedjavadi
collection DOAJ
description Fungal species resistant to current antifungal agents are considered as a serious threat to human health, the dilemma that has dragged attentions toward other sources of antifungals such as antimicrobial peptides (AMPs). In order to improve biological activity of a recently described antifungal peptide MCh-AMP1 from Matricaria chamomilla flowers, MCh-AMP1dimer (DiMCh-AMP1), containing 61 amino acid residues connected by flexible linker (GPDGSGPDESGPDES), was designed and expressed in Escherichia coli, and its structure was analyzed using bioinformatics tools. DiMCh-AMP1 synthetic gene was cloned into pET-28a expression vector, which was then used to transform E. coli BL21 (DE3) strain. His-tag purification was achieved using metal-chelate affinity chromatography. Because there is no methionine residue in the DiMCh-AMP1 sequence, cyanogen bromide was successfully used to separate the target product from the tag. Reverse-phase high-performance liquid chromatography was used as the final step of purification. Results showed that recombinant peptide was produced in considerable amounts (0.9 mg/L) with improved antifungal activity toward both yeasts and molds compared to its monomeric counterpart. The minimum inhibition concentration and minimum fungicidal concentration values of DiMCh-AMP1 against Candida and Aspergillus species were reported in the range of 1.67–6.66 μM and 3.33–26.64 μM, respectively. Our results showed that while antifungal activity of dimerized peptide was improved considerably, its cytotoxicity was decreased, implying that DiMCh-AMP1 could be a potential candidate to design an effective antifungal agent against pathogenic yeasts and molds.
first_indexed 2024-12-21T18:34:54Z
format Article
id doaj.art-a3404cea4e1e4efdaed823543aa690da
institution Directory Open Access Journal
issn 2673-6128
language English
last_indexed 2024-12-21T18:34:54Z
publishDate 2021-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Fungal Biology
spelling doaj.art-a3404cea4e1e4efdaed823543aa690da2022-12-21T18:54:11ZengFrontiers Media S.A.Frontiers in Fungal Biology2673-61282021-04-01210.3389/ffunb.2021.638595638595Design, Dimerization, and Recombinant Production of MCh-AMP1–Derived Peptide in Escherichia coli and Evaluation of Its Antifungal Activity and CytotoxicitySima Sadat Seyedjavadi0Soghra Khani1Jafar Amani2Raheleh Halabian3Mehdi Goudarzi4Hamideh Mahmoodzadeh Hosseini5Ali Eslamifar6Masoomeh Shams-Ghahfarokhi7Abbas Ali Imani Fooladi8Mehdi Razzaghi-Abyaneh9Department of Mycology, Pasteur Institute of Iran, Tehran, IranDepartment of Mycology, Pasteur Institute of Iran, Tehran, IranApplied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, IranApplied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, IranDepartment of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IranApplied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, IranDepartment of Clinical Research, Pasteur Institute of Iran, Tehran, IranDepartment of Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IranApplied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, IranDepartment of Mycology, Pasteur Institute of Iran, Tehran, IranFungal species resistant to current antifungal agents are considered as a serious threat to human health, the dilemma that has dragged attentions toward other sources of antifungals such as antimicrobial peptides (AMPs). In order to improve biological activity of a recently described antifungal peptide MCh-AMP1 from Matricaria chamomilla flowers, MCh-AMP1dimer (DiMCh-AMP1), containing 61 amino acid residues connected by flexible linker (GPDGSGPDESGPDES), was designed and expressed in Escherichia coli, and its structure was analyzed using bioinformatics tools. DiMCh-AMP1 synthetic gene was cloned into pET-28a expression vector, which was then used to transform E. coli BL21 (DE3) strain. His-tag purification was achieved using metal-chelate affinity chromatography. Because there is no methionine residue in the DiMCh-AMP1 sequence, cyanogen bromide was successfully used to separate the target product from the tag. Reverse-phase high-performance liquid chromatography was used as the final step of purification. Results showed that recombinant peptide was produced in considerable amounts (0.9 mg/L) with improved antifungal activity toward both yeasts and molds compared to its monomeric counterpart. The minimum inhibition concentration and minimum fungicidal concentration values of DiMCh-AMP1 against Candida and Aspergillus species were reported in the range of 1.67–6.66 μM and 3.33–26.64 μM, respectively. Our results showed that while antifungal activity of dimerized peptide was improved considerably, its cytotoxicity was decreased, implying that DiMCh-AMP1 could be a potential candidate to design an effective antifungal agent against pathogenic yeasts and molds.https://www.frontiersin.org/articles/10.3389/ffunb.2021.638595/fullantifungal activitycytotoxicityantimicrobial peptideAspergillusCandidadimeric antifungal peptides
spellingShingle Sima Sadat Seyedjavadi
Soghra Khani
Jafar Amani
Raheleh Halabian
Mehdi Goudarzi
Hamideh Mahmoodzadeh Hosseini
Ali Eslamifar
Masoomeh Shams-Ghahfarokhi
Abbas Ali Imani Fooladi
Mehdi Razzaghi-Abyaneh
Design, Dimerization, and Recombinant Production of MCh-AMP1–Derived Peptide in Escherichia coli and Evaluation of Its Antifungal Activity and Cytotoxicity
Frontiers in Fungal Biology
antifungal activity
cytotoxicity
antimicrobial peptide
Aspergillus
Candida
dimeric antifungal peptides
title Design, Dimerization, and Recombinant Production of MCh-AMP1–Derived Peptide in Escherichia coli and Evaluation of Its Antifungal Activity and Cytotoxicity
title_full Design, Dimerization, and Recombinant Production of MCh-AMP1–Derived Peptide in Escherichia coli and Evaluation of Its Antifungal Activity and Cytotoxicity
title_fullStr Design, Dimerization, and Recombinant Production of MCh-AMP1–Derived Peptide in Escherichia coli and Evaluation of Its Antifungal Activity and Cytotoxicity
title_full_unstemmed Design, Dimerization, and Recombinant Production of MCh-AMP1–Derived Peptide in Escherichia coli and Evaluation of Its Antifungal Activity and Cytotoxicity
title_short Design, Dimerization, and Recombinant Production of MCh-AMP1–Derived Peptide in Escherichia coli and Evaluation of Its Antifungal Activity and Cytotoxicity
title_sort design dimerization and recombinant production of mch amp1 derived peptide in escherichia coli and evaluation of its antifungal activity and cytotoxicity
topic antifungal activity
cytotoxicity
antimicrobial peptide
Aspergillus
Candida
dimeric antifungal peptides
url https://www.frontiersin.org/articles/10.3389/ffunb.2021.638595/full
work_keys_str_mv AT simasadatseyedjavadi designdimerizationandrecombinantproductionofmchamp1derivedpeptideinescherichiacoliandevaluationofitsantifungalactivityandcytotoxicity
AT soghrakhani designdimerizationandrecombinantproductionofmchamp1derivedpeptideinescherichiacoliandevaluationofitsantifungalactivityandcytotoxicity
AT jafaramani designdimerizationandrecombinantproductionofmchamp1derivedpeptideinescherichiacoliandevaluationofitsantifungalactivityandcytotoxicity
AT rahelehhalabian designdimerizationandrecombinantproductionofmchamp1derivedpeptideinescherichiacoliandevaluationofitsantifungalactivityandcytotoxicity
AT mehdigoudarzi designdimerizationandrecombinantproductionofmchamp1derivedpeptideinescherichiacoliandevaluationofitsantifungalactivityandcytotoxicity
AT hamidehmahmoodzadehhosseini designdimerizationandrecombinantproductionofmchamp1derivedpeptideinescherichiacoliandevaluationofitsantifungalactivityandcytotoxicity
AT alieslamifar designdimerizationandrecombinantproductionofmchamp1derivedpeptideinescherichiacoliandevaluationofitsantifungalactivityandcytotoxicity
AT masoomehshamsghahfarokhi designdimerizationandrecombinantproductionofmchamp1derivedpeptideinescherichiacoliandevaluationofitsantifungalactivityandcytotoxicity
AT abbasaliimanifooladi designdimerizationandrecombinantproductionofmchamp1derivedpeptideinescherichiacoliandevaluationofitsantifungalactivityandcytotoxicity
AT mehdirazzaghiabyaneh designdimerizationandrecombinantproductionofmchamp1derivedpeptideinescherichiacoliandevaluationofitsantifungalactivityandcytotoxicity